Oncopeptides AB Financial Overview
Oncopeptides AB's market cap is currently kr1.18B. The company's EPS TTM is kr-0.27; its P/E ratio is -3.97; Oncopeptides AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is kr-0.19. See an overview of income statement, balance sheet, and cash flow financials.
